Development of thermosensitive chitosan/glicerophospate injectable in situ gelling solutions for potential application in intraoperative fluorescence imaging and local therapy of hepatocellular carcinoma: A preliminary study

Expert Opinion on Drug Delivery

Volumn 12, Issue 10, 2015, Pages 1583-1596

  Salis, Andrea ^a   Rassu, Giovanna ^a   Budai Szucs, Maria ^b   Benzoni, Ilaria ^c   Csányi, Erzsébet ^b   Berkó, Szilvia ^b   Maestri, Marcello ^c   Dionigi, Paolo ^d   Porcu, Elena P ^d   Gavini, Elisabetta ^a   Giunchedi, Paolo ^a  

^a UNIVERSITY OF SASSARI   (Italy)

^b UNIVERSITY OF SZEGED   (Hungary)

^c FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^d UNIVERSITY OF PAVIA   (Italy)

Author keywords

chitosan; glycerophosphate; hepatocellular carcinoma; indocyanine green; stimuli sensitive hydrogel; transarterial embolization

Indexed keywords

CHITOSAN; CHITOSAN GLYCEROPHOSPHATE; GLYCEROPHOSPHATE; INDOCYANINE GREEN; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; COLORING AGENT; DRUG IMPLANT; GEL; SOLUTION AND SOLUBILITY;

ARTICLE; ARTIFICIAL EMBOLISM; BIODEGRADABILITY; CROSS LINKING; DEACETYLATION; EX VIVO STUDY; FLUORESCENCE IMAGING; GELATION; HEAT SENSITIVITY; HUMAN; HYDROGEL; HYDROGEN BOND; LIVER CELL CARCINOMA; LIVER RESECTION; LOCAL THERAPY; LOW TEMPERATURE; NONHUMAN; PH; PHASE TRANSITION; POLYMERIZATION; PRECIPITATION; SHEAR RATE; SHEAR STRESS; STATIC ELECTRICITY; VISCOMETRY; VISCOSITY; ANIMAL; BIODEGRADABLE IMPLANT; BOVINE; CARCINOMA, HEPATOCELLULAR; CHEMISTRY; DIAGNOSTIC IMAGING; DRUG DELIVERY SYSTEM; DRUG IMPLANT; GEL; INTRAARTERIAL DRUG ADMINISTRATION; LIVER NEOPLASMS; MEDICINAL CHEMISTRY; SOLUTION AND SOLUBILITY; TEMPERATURE;

ABSORBABLE IMPLANTS; ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CATTLE; CHEMISTRY, PHARMACEUTICAL; CHITOSAN; COLORING AGENTS; DIAGNOSTIC IMAGING; DRUG DELIVERY SYSTEMS; DRUG IMPLANTS; GELS; GLYCEROPHOSPHATES; INDOCYANINE GREEN; INJECTIONS, INTRA-ARTERIAL; LIVER NEOPLASMS; PHARMACEUTICAL SOLUTIONS; TEMPERATURE; VISCOSITY;

EID: 84942106547     PISSN: 17425247     EISSN: 17447593     Source Type: Journal    
DOI: 10.1517/17425247.2015.1042452     Document Type: Article

References (46)

1. Ferenci P, Fried M, Labrecque D, et al. Hepatocellular carcinoma (HCC): A global perspective. J Clin Gastroenterol 2010;44:239-45
2. Tam KY, Leung KC, Wang YX. Chemoembolization agents for cancer treatment. Eur J Pharm Sci 2011;44:1-10
3. Giunchedi P, Maestri M, Gavini E, et al. Transarterial chemoembolization of hepatocellular carcinoma. Agents and drugs: An overview. Part 1. Expert Opin Drug Deliv 2013;10:679-90
4. Breedos C, Young G. The blood supply of neoplasms in the liver. Am J Pathol 1954;30:969-77
5. Kemeny NE, Niedzwiecki D, Hollis DR, et al. Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: A randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481). J Clin Oncol 2006;24:1395-403
6. Raoul JL, Heresbach D, Bretagne JF, et al. Chemoembolization of hepatocellular carcinomas. A study of the biodistribution and pharmacokinetics of doxorubicin. Cancer 1992;70:585-90
7. Laurent A. Microspheres and nonspherical particles for embolization. Tech Vasc Interv Radiol 2007;10:248-56
8. Giunchedi P, Maestri M, Gavini E, et al. Transarterial chemoembolization of hepatocellular carcinoma. Agents and drugs: An overview. Part 2. Expert Opin Drug Deliv 2013;10:799-810
9. Lewis AL, Gonzalez MV, Lloyd AW, et al. DC Bead: in vitro characterization of a drug-delivery device for transarterial chemoembolization. J Vasc Interv Radiol 2006;17:335-42
10. Landsman ML, Kwant G, Mook G. A, et al. Light-absorbing properties, stability, and spectral stabilization of indocyanine green. J Appl Physiol 1976;40:575-83
11. Gotoh H, Yamada T, Ishikawa O, et al. A Novel Image-Guided Surgery of Hepatocellular Carcinoma by Indocyanine Green Fluorescence Imaging Navigation. J Surg Oncol 2009;100:75-9
12. Ishizawa T, Fukushima N, Shibahara J, et al. Real-time identification of liver cancers by using indocyanine green fluorescent imaging. Cancer 2009;115:2491-504
13. Kokudo N, Ishizawa T. Clinical application of fluorescence imaging of liver cancer using indocyanine green. Liver Cancer 2012;1:15-21
14. Ishizawa T, Masuda K, Urano Y, et al. Mechanistic background and clinical applications of indocyanine green fluorescence imaging of hepatocellular carcinoma. Ann Surg Oncol 2014;21:440-8
15. Alacam B, Yazici B, Intes X, et al. Extended Kalman filtering for the modeling and analysis of ICG pharmacokinetics in cancerous tumors using NIR optical methods. IEEE Trans Biomed Eng 2006;53:1861-71
16. Peloso A, Franchi E, Canepa MC, et al. Combined use of intraoperative ultrasound and indocyanine green fluorescence imaging to detect liver metastases from colorectal cancer. HPB (Oxford) 2013;15:928-34
17. Unno N, Inuzuka K, Suzuki M, et al. Preliminary experience with a novel fluorescence lymphography using indocyanine green in patients with secondary lymphedema. J Vasc Surg 2007;45:1016-21
18. Qiu Y, Park K. Environment-sensitive hydrogels for drug delivery. Adv Drug Deliv Rev 2001;53:321-39
19. Klouda L, Mikos AG. Thermoresponsive hydrogels in biomedical applications. Eur J Pharm Biopharm 2008;68:34-45
20. Wang J, Pang Q, Liu Z, et al. A new liquid agent for endovascular embolization: initial clinical experience. ASAIO J 2009;55:494-7
21. Weng LN, Zantek ND, Rostamzadeh P, et al. An in situ forming biodegradable hydrogel-based embolic agent for interventional therapies. Acta Biomater 2013;9:8182-91
22. Muzzarelli RAA. Human enzymatic activities related to the therapeutic administration of chitin derivatives. Cell Mol Life Sci 1997;53:131-40
23. Hirano S, Seino H, Akiyama Y, et al. Chitosan: A biocompatible material for oral and intravenous administrations. In: Progress in biomedical polymers. Springer; USA: 1990. p. 283-90
24. Rassu G, Gavini E, Mattana A, et al. Improvement of antiamoebic activity of rokitamycin loaded in chitosan microspheres. Open Drug Deliv J 2008;2:38-43
25. Chenite A, Chaput C, Wand D, et al. Novel injectable neutral solutions of biodegradable gels in situ. Biomaterials 2000;1:2155-61
26. Chenite A, Buschmann MD, Wang D, et al. Rheological characterisation of thermogelling chitosan/glycerolphosphate solutions. Carbohydr Polym 2001;46:39-47
27. Kashyap A, Viswanad B, Sharma G, et al. Design and evaluation of biodegradable, biosensitive in-situ gelling system for pulsatile delivery of insulin. Biomaterials 2007;28:2051-60
28. Gupta D, Tator CH, Shoichet MS. Fast-gelling injectable blend of hyaluronan and methylcellulose for intrathecal, localized delivery to the injured spinal cord. Biomaterials 2006;27:2370-9
29. Zang S, Dong G, Peng B, et al. A comparison of physicochemical properties of sterilized chitosan hydrogel and its applicability in a canine model of periodontal regeneration. Carbohydr Polym 2014;113:240-8
30. Ahmadi R, De Bruijn JD. Biocompatibility and gelation of chitosan-glycerol phosphate hydrogels. J Biomed Mater Res A 2007;86A:824-32
31. Ruel-Gariepy E, Leclair G, Hildgen P, et al. Thermosensitive chitosan-based hydrogel containing liposomes for the delivery of hydrophilic molecules. J Control Release 2002;82:373-83
32. Wu H, Zhao H, Song X, et al. Self-assembly-induced near-infrared fluorescence nanoprobes for effective tumor molecular imaging. J Mater Chem B 2014;2:5302-8
33. Jauhari S, Dash AK. A mucoadhesive in situ gel delivery system for paclitaxel. AAPS PharmSciTech 2006;7:154-9
34. Zhou HY, Chen XG, Kong M, et al. Preparation of chitosan-based thermosensitive hydrogels for drug delivery. J Appl Polym Sci 2009;112:1509-15
35. Ruel-Gariepy E, Chenite A, Chaput C, et al. Characterization of thermosensitive chitosan gels for the sustained delivery of drugs. Int J Pharm 2000;203:89-98
36. Back JF, Oakenfull D, Smith MB. Increased thermal stability of proteins in the presence of sugars and polyols. Biochemistry 1979;18:5191-6
37. Coutu JM, Fatimi A, Berrahmoune S, et al. A new radiopaque embolizing agent for the treatment of endoleaks after endovascular repair: influence of contrast agent on chitosan thermogel properties. J Biomed Mater Res B Appl Biomater 2013;101B:153-61
38. Khan I, Vasudevan V, Nallagatla S, et al. Acute lung injury following transcatheter hepatic arterial chemoembolization of doxorubicin-loaded LC beads in a patient with hepatocellular carcinoma. Lung India 2012;29:169-72
39. Wu JJ, Chao M, Zhang GQ, et al. Pulmonary and cerebral lipiodol embolism after transcatheter arterial chemoembolization in hepatocellular carcinoma. World J Gastroenterol 2009;15:633-5
40. Shiah HS, Liu TW, Chen LT, et al. Pulmonary embolism after transcatheterarterial chemoembolization. Eur J Cancer Care (Engl) 2005;14:440-2
41. Naorungroj T, Naksanguan T, Chinthammitr Y. Pulmonary lipiodol embolism after transcatheter arterial chemoembolization for hepatocellular carcinoma: A case report and literature review. J Med Assoc Thai 2013;96:270-5
42. Zhao H, Wang HQ, Fan QQ, et al. Rare pulmonary and cerebral complications after transarterial chemoembolisation for hepatocellular carcinoma: A case report. World J Gastroenterol 2008;14:6425-7
43. Lapasin R, Pricl S. Rheology of industrial polysaccharides: theory and applications. Springer, London: 1995
44. Ganji F, Abdekhodaie MJ, Ramazani ASA. Gelation time and degradation rate of chitosan-based injectable hydrogel. J Sol-Gel Sci Techn 2007;42:47-53
45. Dang QF, Yan JQ, Li JJ, et al. Controlled gelation temperature, pore diameter and degradation of a highly porous chitosan-based hydrogel. Carbohydr Polym 2011;63:171-8
46. Drury JL, Mooney DJ. Hydrogels for tissue engineering: scaffold design variables and applications. Biomaterials 2003;24:4337-51